Elena Rizova

Elena Rizova, MD, PhD, leads the immuno-inflammatory Global Medical Affairs team of Dupilumab atopic dermatitis at Sanofi Genzyme. Her areas of interest include dermatology, immunology, and immunoinflammation. She is an expert in drug development and launch of new entities in dermatology, immunology, oncology, CNS, infectious and cardiovascular diseases. Clinical research, scientific thought leaders education and advocacy are among her core competencies.



E-Posters by Elena Rizova
Conjunctivitis adverse events in dupilumab clinical trials
Conjunctivitis adverse events in dupilumab clinical trials